Company Filing History:
Years Active: 2018
Title: Margarita Marinova: Innovator in Enzymatic Activity
Introduction
Margarita Marinova is a notable inventor based in Columbia, SC (US). She has made significant contributions to the field of enzymatic activity, particularly through her innovative patent work. Her research focuses on enhancing the performance of lactobacillus beta-glucuronidase enzymes, which have important applications in drug analysis.
Latest Patents
Margarita holds a patent for "Mutant lactobacillus beta-glucuronidase enzymes with enhanced enzymatic activity." This invention features mutated strain 269Y β-glucuronidase enzymes that exhibit improved enzymatic activity at low pH levels, specifically below pH 6.8. Additionally, these enzymes demonstrate enhanced thermostability compared to the wild type enzyme. The advantages of her invention include the ability to accurately analyze bodily samples for the presence of drugs in 30 minutes or less, a significant improvement over the several hours required by previous enzyme preparations. The patent also outlines methods for using these mutated enzymes to hydrolyze glucuronide substrates, including opiates and benzodiazepines.
Career Highlights
Margarita is associated with Integrated Micro-chromatography Systems, Inc., where she applies her expertise in enzymatic research. Her work has positioned her as a key figure in the development of rapid drug analysis techniques.
Collaborations
Margarita collaborates with notable colleagues, including Jia Yang and Gary Horvath, who contribute to her research endeavors and innovations.
Conclusion
Margarita Marinova's contributions to enzymatic activity and drug analysis exemplify her innovative spirit and dedication to advancing scientific research. Her patented work not only enhances the efficiency of drug detection but also showcases the potential of mutated enzymes in medical applications.